Turmeric for Patients With Basal Joint Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03017118|
Recruitment Status : Recruiting
First Posted : January 11, 2017
Last Update Posted : August 28, 2019
|Condition or disease||Intervention/treatment||Phase|
|Thumb Osteoarthritis||Dietary Supplement: Turmeric Other: Placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis|
|Actual Study Start Date :||August 9, 2017|
|Estimated Primary Completion Date :||June 2020|
|Estimated Study Completion Date :||July 2020|
Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Dietary Supplement: Turmeric
Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Placebo Comparator: Control
Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.
Subjects in the control group will receive a placebo 3 times per day for 6 weeks.
- Change in baseline pain intensity [ Time Frame: Enrollment, 6 weeks, and 3 months ]0-10 ordinal rating of pain intensity
- Change in baseline disability [ Time Frame: Enrollment, 6 weeks, and 3 months ]Disability measured by the QuickDASH
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03017118
|Contact: Neal Chen, M.D.||firstname.lastname@example.org|
|Contact: Kiera Lunn, BScemail@example.com|
|Principal Investigator:||Neal Chen, MD||Massachusetts General Hospital|